• English
  • 简体中文
  • 繁體中文
  • Tiếng Việt
  • ไทย
  • Indonesia
Subscribe
Real-time News
On July 8th, China Biopharmaceutical (01177.HK) announced a further deepening of its strategic cooperation with GlaxoSmithKline (GSK.N). Under the expanded cooperation agreement, Chia Tai Tianqing Pharmaceutical Group, a subsidiary of China Biopharmaceutical, will be fully responsible for the import, distribution, hospital access, and promotion of two innovative respiratory drugs in mainland China: Flutemetixyl Inhalation Powder (Tronex) and Umemetidine-Vilanterol Inhalation Powder (Olex). Previously, the two companies had already reached a cooperation agreement on the localization of innovative drugs in the field of liver disease.Bernstein: Lowered its price target for Netflix (NFLX.O) from $110 to $100.Citigroup raised its price target for Johnson & Johnson (JNJ.N) from $285 to $298.Broadcom (AVGO.O) recovered some of its losses in pre-market trading and is currently down 0.5%. The company has reached an agreement with Apple (AAPL.O) to produce more than 15 billion chips.On July 8, Xi Jinping attended the National Science and Technology Awards Conference, the General Assembly of the Chinese Academy of Sciences and the Chinese Academy of Engineering, and the 11th National Congress of the China Association for Science and Technology, and delivered an important speech. Xi Jinping emphasized the need to promote the deep integration of scientific and technological innovation and industrial innovation, and to open up channels for the accelerated transformation of science and technology into real productive forces. Scientific and technological innovation should be application-oriented, while industrial innovation should focus on raising scientific questions. He stressed strengthening the national technology transfer system, creating diversified application scenarios and high-level industrial clusters, and promoting the application and iterative upgrading of independently developed technologies and products. He also called for improving the intellectual property protection system and building a science and technology finance system adapted to scientific and technological innovation.

US Inflation Cools to 8.3% but Eases Less than Forecast, Nasdaq 100 Sinks as Yields Rise

Cory Russell

May 12, 2022 10:40

微信截图_20220419102342.png


Inflation in the United States decreased in annual terms last month, but remained at multi-decade highs and more than four times the Federal Reserve's 2 percent goal, according to Labor Department statistics published on Wednesday.


According to the latest report from the agency, the consumer price index increased 0.3 percent in April after rising 1.2 percent in March, bringing the 12-month reading to 8.3 percent from 8.5 percent, indicating that inflationary pressures reached their peak at the end of the first quarter but are still struggling to cool materially. CPI was expected to grow 0.2 percent month over month and 8.1 percent year over year, according to analysts polled by Bloomberg News.


When looking at the monthly drivers of the headline statistic, food costs increased by 0.9 percent, keeping pace with previous rises in this category. Meanwhile, energy expenses declined by 2.7 percent after rising by 11% in March due to rising oil prices after Russia's invasion of Ukraine. This is a good sign since it means the worst of the commodities market shock may have passed.


Excluding food and energy, the core CPI rose 0.6 percent on a seasonally adjusted basis and 6.2 percent year over year, reducing transient noise and reflecting longer-term economic trends. The decrease in the annual number, which fell from 6.5 percent, tends to support the hypothesis that the core gauge peaked in March as well.

 

The shelter index gained 0.5 percent in monthly contributions for the core indicator, mirroring the previous two months' growth, despite a tight rental market. Meanwhile, transportation increased by 3.1 percent, indicating a shift in household demand toward service spending. Used automobiles and trucks, on the other hand, continued to tumble, down 0.4 percent after losing 3.8 percent in March due to cooling demand and lowering durable-goods prices.


With inflation decreasing but not falling much, it's unclear if we've hit the apex of central bank policy hawkishness. In this environment, yields may continue to rise on anticipation of a more aggressive tightening reaction. This scenario might heighten worries that the Fed's rate hikes would lead to a recession, depressing confidence and hindering the stock market's rebound.


U.S. Treasury rates surged immediately after the CPI statistics were released, causing the Nasdaq 100 futures to lose all of their pre-market gains and fall more than 1% into negative territory. Officials from the Federal Reserve have said that they support interest rate rises in half-percentage-point increments, but have shown little taste for greater changes. At the face of persistent inflation, the bank may opt for large 75-basis-point rises in upcoming sessions in order to get monetary policy closer to neutral sooner. Stocks are at danger as a result of this.